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Abstract. 
The controlled assembly in solution of gold nanocrystals modified by 
attachment of complementary protein- DNA conjugates is described. The 
size of the aggregates formed can be controlled by the addition of 
singlestranded DNA, which quickly terminates the assembly process. The 
rate of formation of the aggregates can also be controlled by varying the 
salt concentration. Consequently, two distinct regimes of aggregation 
kinetics are observed. At low salt concentrations, aggregation is shown to 
be dependent on the rate of duplex formation between the modified gold 
nanocrystals, i.e., reaction-limited. At higher salt concentrations, 
aggregation is shown to be dependent only on the rate of diffusion of the 
nanocrystals, i.e., diffusion-limited. The results presented provide important 
insights into the rates of formation of nanocrystal assemblies. Moreover, the 
approach adopted is modular, requiring only the relevant biotin linker 
chemistry to be developed for a given nanoparticle, while also precluding 
unfavorable interactions between the DNA and the streptavidin-coated 
nanoparticle. The ability to control the rate of formation and size of 
nanocrystal aggregates assembled is important new knowledge. Application 
of this knowledge will inform future studies of nanocrystal assembly in 
solution involving different types of nanocrystals, which is of increasing 
technological significance. 
 
 
Introduction 
 
Recent advances in the synthesis and characterization of size monodisperse 
nanocrystals have led to insights into the unique optical and electronic 
properties of these materials (1, 2). It has been suggested that the ability 
to control the assembly of nanocrystals in solution and at patterned 
substrates will allow aspects of the technological potential of these materials 
to be fully exploited. A number of key developments, which represent 
progress toward these goals, have been described (3-22). One such 
development involves using high-information-content biomolecules, 
including DNA, to program the assembly of nanocrystals in solution. 
DNA molecules have previously been used as linker and template 
molecules for the assembly of nanocrystals (23, 24). For example, gold 
nanocrystals have been surface-modified by oligonucleotides that are 
capable of recognizing and selectively binding part of the linker or template 
oligonucleotide strand. This approach has led to novel arrangements of 
nanocrystals and has also provided a basis for binary nanocrystal assembly 
in solution (25-28). Related work based on protein-DNA conjugates, similar 
to those used in this paper, has also enabled chemists and molecular 
biologists to assemble and uniquely define the position of nanocrystals 
within nanocrystal-protein- DNA assemblies (29-31). 
The inherent recognition properties of biological macromolecules, 
such as DNA and proteins, and the associated diversity of interactions and 
binding energies, ranging from hydrogen bonding to covalent bonding, 
should allow the self-assembly of complex nanoscale structures whose 
complexity approaches those found in nature. In order, however, to 
successfully use biological macromolecules to program the assembly of 
these complex nanoscale structures in solution, a significant degree of 
control over the size and order of the nanocrystal assemblies will be 
necessary. If this can be achieved, the promise of the outlined approach 
may become possible. 
 
 
 
SCHEME 1: Gold Nanocrystals Are Modified by Chemisorption of 
DSDA. Subsequent Addition of Streptavidin Leads to Aggregation of 
the Dispersion 
 
In this context, we recently developed a system based on the 
streptavidin-mediated assembly of biotin-modified gold nanocrystals, which 
has previously been reported (Scheme 1) (32). A model of this aggregation 
has also been developed which is an extension of both the classical 
Smoluchowski model of aggregation and a more recently developed model 
of linker induced aggregation by Kisak et al. (33-35). 
In this paper, we report a unique approach to the self-assembly of 
gold nanocrystals in solution using DNA oligomers (Scheme 2). By 
modifying gold nanocrystals with a biotin analogue, the nanocrystals are 
programmed to recognize and bind selectively streptavidin-DNA conjugates. 
The addition of gold nanocrystals, similarly programmed to recognize and 
bind selectively the complementary streptavidin-DNA conjugate, is expected 
to result in nanocrystal assembly. DNA duplex formation between the two 
complementary DNA oligomers bound to the individual nanocrystals drives 
the assembly process. The addition of a DNA linker or template molecule to 
initiate the assembly process is also unnecessary. 
 
 
 
SCHEME 2: Gold Nanocrystals Are Modified by Chemisorption of 
DSDA. They Are Further Modified by Addition of Complementary 
Streptavidin-DNA Conjugates to Separate Sets of Nanocrystals. 
Subsequent Combination of Both Sets of Nanocrystals Results in 
Duplex Formation between the Complementary DNA-Modified 
Nanocrystals and Aggregation of the Dispersion 
 
This unique approach allows the kinetics of nanocrystal assembly to 
be controlled. Moreover, it is possible to terminate aggregation of a 
dispersion of nanocrystals at any time by the addition of single-stranded 
DNA (ssDNA) oligomers. Consequently, it is possible to control the rate of 
formation and size of the resultant assemblies. 
Finally, it should be noted that the approach adopted is modular, 
requiring only the relevant biotin linker chemistry to be developed for a 
given nanoparticle, while also precluding unfavorable interactions between 
the DNA and the streptavidincoated nanoparticle. 
 
Experimental Section 
 
All chemicals were used as supplied by the Sigma-Aldrich Chemical 
Co. Ltd, unless otherwise stated. The disulfide desthiobiotin analogue 
(DSDA) was prepared as previously described.33 Distilled deionized 
Millipore-MilliQ water (18 Ώ cm-1) filtered through a 0.02 µm inorganic 
Anotop filter was used to prepare all solutions. 
 
Preparation of Oligonucleotides. The 5’-biotin-hexaethylene 
glycol-oligonucleotides were prepared using an automatic DNA Synthesizer 
(ABI Model 392) and a LV200 synthesis cycle (Applied Biosystems, USA). 
Biotin-hexaethylene glycol moieties were introduced at the 5’-terminus of 
the 20 base-pair synthetic oligonucleotides by using hexaethylene glycol 
phosphoramidite (Glen Research, USA) and biotin phosphoramidite (Applied 
Biosystems, USA). The polystyrene supports used were LV200 columns 
(Applied Biosystems, USA). The coupling time of the biotin and the 
hexaethylene glycol phosphoramidites was increased from 30 to 480 s. 
After the assembly of the sequences, the oligonucleotide supports were 
treated with 32% aqueous ammonia at 55 ºC for 16 h. The ammonia 
solutions were concentrated to dryness and the products were purified by 
reverse-phase HPLC. Oligonucleotides were synthesized with the last DMT 
group at the 5’-end to help reverse-phase purification. The sequences 
prepared were: 5’-biotin-hexaethylene glycol-CAG TAG TCA GTA GTA GTC 
AG-3’ (ssA); 5’-biotin-hexaethylene glycol-CTG ACT ACT ACT GAC TAC TG 
3’ (ssA’). Following the oligonucleotide synthesis, both sets of 
oligonucleotides were lyophilized and stored at -20 ºC prior to use. 
 
UV-Visible Spectroscopy. UV-visible spectroscopy was performed 
using a HP-8452A Spectrophotometer using LabView software written to 
acquire data. All UV-visible spectra were referenced using appropriate 
solution backgrounds. 
 
Dynamic Light Scattering. Dynamic light scattering (DLS) 
experiments were performed using a Malvern PCS-4700 instrument 
equipped with a 256-channel correlator. The laser source was the 488.0 nm 
line of a Coherent Innova-70 Ar ion laser typically at a power of 50 mW. 
The temperature was maintained at 20 ºC ± 0.02 ºC by an external 
circulator. Data treatment was as previously described (36). Scattered light 
was monitored at an angle of 90º. 
 
Transmission Electron Microscopy. Transmission electron 
microscopy (TEM) was performed on a JEOL JEL-2000 EX electron 
microscope at an accelerating voltage of 80 kV. Samples were prepared by 
evaporating a drop of the aqueous dispersion on a carbon-coated copper 
grid. 
 
Preparation of Buffers. Buffer A consists of 8.75 mL of a 1% w/v 
aqueous citrate solution diluted to 250 mL, pH 7.2. Buffer B consists of 
aqueous 10 mM phosphate, 0.1% w/v Tween20, 2 mM sodium azide 
solution, pH 7.2. Buffer C consists of a 10 mM phosphate, 1 M NaCl, 0.1% 
w/v Tween20, 2 mM sodium azide solution, pH 7.2. 
 
Preparation of Disulfide Desthiobiotin Analogue-Modified Gold 
Nanocrystals (Au-DSDA). Gold nanocrystal dispersions with narrow size 
distributions (approximately 16 nm) were prepared by a modification of the 
Frens method as previously described (32). Modification of the gold 
nanocrystals with DSDA was carried out by the addition of an aliquot of 
DSDA solution in Buffer A (14 µM, 5 mL) to the gold sol (2 nM, 250 mL). 
The dispersion was sonicated (Ultrawave, USA) for 1 h and shaken on a 
minishaker-vortex (IKA Works Inc., USA) for 1 h. The modified gold sol, 
referred to as Au-DSDA, was concentrated by centrifugation (9000 rpm, 25 
min; Sorvall, SS34-rotor), briefly sonicated (<5 s), and then filtered using a 
0.1 µm Anotop syringe filter membrane. The concentrated sample was 
redispersed in Buffer A and characterized by UV-visible spectroscopy (for 
the Au-DSDA sol and the resulting modified nanocrystal dispersions an 
extinction coefficient of 4.712 x 108 L mol-1 cm-1 at 518 nm was used to 
determine the nanocrystal concentration), DLS and TEM. 
 
Preparation of Streptavidin Solutions. Streptavidin was dissolved 
in deionized Milli-Q Millipore water to a final concentration of 80 µM and 
stored at 4 ºC. The activity of the resulting solution was subsequently 
determined by titration using UV-visible spectroscopy (36). All other 
streptavidin solutions were prepared using Buffer A and stored at 4 ºC prior 
to use. 
 
Preparation of Oligonucleotide Solutions (ssA, ssA’). The 
lyophilized oligonucleotides were dissolved in Buffer A, unless otherwise 
stated, and stored at 4 ºC prior to use. The concentrations of the resulting 
solutions were based on an extinction coefficient of 2.080 x 105 L mol-1 cm-1 
for ssA and 1.856 x 105 L mol-1 cm-1 for ssA’ at 260 nm (38). 
 
Preparation of Streptavidin-Oligonucleotide Conjugates (STP-
ssA, STP-ssA’). The 1:1 streptavidin-oligonucleotide conjugate, STP-ssA, 
was prepared by the addition of a solution of ssA (2 µM, 500 µL) to a 
solution of streptavidin (2 µM, 500 µL) in a 3 mL glass vial. The resulting 
solution was agitated using the minishaker for 24 h at room temperature. 
During this period, the solution was sonicated briefly (<5 s) at hourly 
intervals to prevent nonspecific adsorption of the streptavidin to the glass. 
The 1:1 streptavidin-oligonucleotide conjugate, STP-ssA’, was prepared in 
a similar manner. 
 
Preparation of Au-DSDA-Streptavidin-Oligonucleotide Adducts 
(Au-D-S-ssA, Au-D-S-ssA’). To a solution of concentrated Au-DSDA (20 
nM, 1 mL) in a glass vial was added STP-ssA (1 µM, 1 mL). The dispersion 
was agitated for 24 h at room temperature, sonicated briefly, and then 
centrifuged (9000 rpm, 25 min). Following removal of the supernatant, the 
dark red precipitate was briefly sonicated and washed once with Buffer A 
using centrifugation (9000 rpm, 25 min). Streptavidin (2 µM, 500 µL) was 
added, and the vial was agitated for 12 h. The dispersion was sonicated, 
centrifuged, and washed (x2) using Buffer A, as described above. An aliquot 
of ssA (2 µM, 1 mL) was then added, and the resulting dispersion was 
agitated for 24 h and washed (x4) with Buffer A as before. The dispersion 
was finally filtered through a 0.1 µM Anotop syringe filter and made up to 1 
mL with Buffer A. This dispersion will be referred to as Au-D-S-ssA. The 
corresponding Au-DSDA-streptavidin- oligonucleotide adduct, Au-D-S-ssA’, 
was prepared similarly. Both adducts were characterized using UVvisible 
spectroscopy, DLS, and TEM. The concentration of each dispersion was 
approximately 20 nM. 
 
DNA-Programmed Assembly of Protein-Modified Gold 
Nanocrystals. DLS was used to characterize the DNAprogrammed 
assembly of the protein-modified gold nanocrystals by monitoring the 
increase in the hydrodynamic radius following the addition of Au-D-S-ssA 
to Au-D-S-ssA’. Typically, an aliquot of Au-D-S-ssA’ (20 nM, 25 µL) was 
added to a solution containing Au-D-S-ssA (20 nM, 25 µL), 850 µíL of 
Buffer B, and 100 µL of Buffer C, giving a final salt concentration of 100 
mM. Samples for TEM were prepared immediately after aggregation by 
removing the relevant sample from the DLS cell.  
To establish that DNA duplex formation is the principle driving force 
for the assembly process, a series of control experiments were also 
performed. First, an aliquot of Au-DS- ssA (20 nM, 25 µL) was added to a 
dispersion containing Au-D-S (20 nM, 25 µL), which corresponds to Au-
DSDA coated with a monolayer of streptavidin (33), in 850 µL of Buffer B 
and 100 µL of Buffer C. A similar control experiment, at corresponding 
concentrations and volumes, was performed by the addition of Au-D-S-ssA’ 
to a dispersion of Au-D-S in 85 µL of Buffer B and 100 µL of Buffer C. For 
this experiment, it was anticipated that omission of the complementary 
oligomer on either set of modified nanocrystals would result in no assembly. 
This is a consequence of the complementary oligomer not being present, 
hence no duplex formation is possible.  
Further control experiments involved the addition of an aliquot of Au-
D-S-ssA’ (20 nM, 25 µL), after 3000 s of aggregation, to a dispersion 
containing Au-D-S-ssA (20 nM, 25 µL) and ssA’ (2 µM, 25 µL) in 825 µL of 
Buffer B and 100 µL of Buffer C. It would be expected that no aggregation 
would be observed since the preformed duplexes between Au-D-SssA and 
ssA’ would ensure that Au-D-S-ssA’ is unable to bind to and form duplexes 
with Au-D-S-ssA. A similar experiment, at corresponding concentrations, 
volumes, and times, was performed by the addition of Au-D-S-ssA to a 
dispersion of Au-D-S-ssA’ and ssA. 
 
Time-Dependence of Size Distribution on Aggregation 
Termination. To terminate the aggregation process and investigate the 
resulting size distributions of the aggregates formed, ssDNA was added to 
an aggregating solution of complementary nanocrystals at various stages of 
the aggregation process. The addition of ssDNA was carried out after 600, 
1500, and 2700 s of aggregation. Typically, this was achieved by the 
addition of a solution of either ssA or ssA’ (2 µM, 25 µL), in Buffer B, to a 
dispersion containing both Au-D-S-ssA (20 nM, 25 µíL) and Au-D-S-ssA’ 
(20 nM, 25 µíL) in 850 µíL of Buffer B and 100 µL of Buffer C. DLS was used 
to monitor the aggregation termination processes, and representative TEM 
samples were taken from the DLS cell upon completion of the experiments. 
 
Salt and Nanocrystal Concentration Dependence on 
Aggregation. To measure the effects of the salt and nanocrystal 
concentrations on the rate of assembly both parameters were varied 
independently of one another. DLS was used to characterize the respective 
aggregation processes as both parameter were varied. First, the 
aggregation of the complementary nanocrystals was monitored at 15, 25, 
50, 100, 200, 400, and 600 mM salt by adjusting the volume ratio of Buffer 
B to Buffer C. For this experiment, the nanocrystal concentration was the 
same as for the preceding section. Second, experiments where the 
nanocrystal concentration was varied were carried out at 100 mM salt. 
Aggregation was monitored at half and twice the nanocrystal concentrations 
used in the preceding section. 
 
 
 
Figure 1. (a) Average hydrodynamic diameter as a function of time 
following successive modifications of the gold sol. (Note: The average 
hydrodynamic diameter values obtained for Au-D-S-ssA and Au-D-S-ssA’ 
in Buffer A correspond to the values shown for the same adducts at 100 mM 
salt concentration). (b) TEM image of a dispersion of Au-D-S-ssA and Au 
D-S-ssA’ aggregated at 100 mM salt concentration. (c) TEM image of Au-
DSDA further modified with streptavidin-DNA conjugate STP-ssA. A similar 
image was obtained for the modification of Au-DSDA with STP-ssA’. (d) 
Average hydrodynamic diameter as a function of time following addition of 
Au-D-S-ssA’ after 3000 s to a dispersion containing Au-D-S-ssA and ssA’. 
Au-D-S-ssA was also added after 3000 s to a dispersion containing Au-D-
S-ssA’ and ssA (See Supporting Information for a graphical illustration of 
this experiment). Also shown is the average hydrodynamic diameter as a 
function of time following addition of Au-DS- ssA to Au-D-S, and the 
addition of Au-D-S-ssA’ to Au-D-S. The arrows indicate the time of 
addition of Au-D-S-ssA (dark gray) and Au-DS- ssA’(light gray). All 
solutions were at a salt concentration of 100 mM. 
 
 
Results and Discussion 
 
The following paragraphs detail the characterization of gold 
nanocrystals modified by protein-DNA conjugates. The assembly of the 
nanocrystals, mediated by DNA duplex formation, and subsequent insights 
into the assembly process are outlined. Specifically, factors that control the 
rate of growth and the size of the resultant aggregates are identified. 
 
Streptavidin-Oligonucleotide-Modified Gold Nanocrystals. The 
assembly of DSDA-modified gold nanocrystals using the tetrameric protein 
streptavidin as a linker has previously been characterized (Scheme 1). It 
has been calculated that there are approximately 150 DSDA molecules per 
nanocrystal, and that 50 streptavidins per nanocrystal correspond to 
monolayer coverage (33). An initial increase of 2 nm in the size of the 
nanocrystals from 16 to 18 nm is observed upon the addition of DSDA 
(Figure 1a). This increase corresponds to a perpendicular alignment of the 
DSDA molecule (approximately 1.5 nm in length) on the surface of the 
charge-stabilized gold nanocrystals (Scheme 1). 
 
In this work, the DSDA-modified gold nanocrystals are subsequently 
modified with a streptavidin-oligonucleotide conjugate (Scheme 2; SII-a, 
SII-c) and a further increase in diameter from 18 to 42 nm is observed 
(Figure 1a). This 24 nm increase in the overall diameter corresponds to the 
binding of an entity approximately 12 nm in length to the surface of the 
DSDA-modified gold (Scheme 2; SII-d, SII-e). This finding is consistent 
with the facts that the dimensions of streptavidin are 4 x 4.2 x 5 nm (39), 
while those of the biotin-hexaethylene glycol-oligonucleotides, ssA and 
ssA’, are approximately 8.5 x 2 nm (40). 
 
Streptavidin itself is a tetrameric protein with four binding sites, and 
the arrangement of these sites is such that two adjacent pairs exist on 
opposite faces of the protein. Consequently, for the 1:1 conjugates, STP-
ssA and STP-ssA’, the biotinhexaethylene glycol-oligonucleotides are free 
to bind to either site available on either face of the protein. Two adjacent 
sites will remain unoccupied on the unbound face, which can bind to the 
DSDA-modified gold because they are sterically unhindered (Scheme 2; 
SII-d, SII-e). The length of such a streptavidin- DNA conjugate is 
approximately 12.5 nm along the major axis. Hence, the binding of an 
entity representative of such dimensions corresponds to the observed 
increase in size. 
 
 
 
 
Figure 2. (a) Average hydrodynamic diameter as a function of time 
following addition of ssDNA oligomer to an aggregating dispersion of Au- D-
S-ssA and Au-D-S-ssA’. The arrows indicate the time of addition of ssDNA 
oligomer after (I) 600, (II) 1500, and (III) 2700 s of aggregation. (Note: 
Similar results were obtained for the addition of either ssA or ssA’ 
oligomers). (b) TEM images corresponding to the addition of ssDNA 
oligomer after (I) 600, (II) 1500, and (III) 2700 s of aggregation. 
 
Programmed Assembly of Protein-DNA Modified Gold 
Nanocrystals. The addition of Au-D-S-ssA to an equimolar dispersion of 
Au-D-S-ssA’, both characterized as described above, at 100 mM salt 
concentration yields a wine-colored precipitate within 1 h (Figure 1b). To 
establish that DNA is the driving force for the aggregation, a series of 
control experiments were performed. Addition of Buffer C to separate 
samples of Au-D-S-ssA and Au-D-S-ssA’, up to a salt concentration of 100 
mM, resulted in no increase in the size of the respective samples (Figure 
1a). Representative TEM images from the same samples (Figure 1c) show 
at most dimer and trimer formation. 
Previous studies would suggest that such entities are formed by 
trace-free streptavidin, at which ssDNA is not bound, crosslinking DSDA-
modified gold. This trace-free streptavidin is introduced when the 1:1 
conjugates, STP-ssA and STP-ssA’, are added to the DSDA-modified 
gold.33 In this instance, although the salt concentration is sufficient for DNA 
duplex formation and hence particle aggregation, no increase in size was 
observed. From this, one can conclude that the DNA strands are non self-
complementary. 
 
 
 
Figure 3. (a) Average hydrodynamic diameter as a function of time for an 
aggregating dispersion of Au-D-S-ssA and Au-D-S-ssA’ at various 
nanocrystal concentrations. (Note: Nanocrystal concentrations are given 
relative to the addition of Au-D-S-ssA (20 nM, 25 µL) to a dispersion 
containing Au-D-S-ssA’ (20 nM, 25 µL) and 950 íL of Buffer B and Buffer C 
at 100 mM salt concentration). (b) Average hydrodynamic diameter as a 
function of time for an aggregating dispersion of Au-D-S ssA and Au-D-S-
ssA’ at various salt concentrations. (c) A log-log plot of rates of aggregation 
for various salt concentrations. (Note: The rates of aggregation correspond 
to the slopes of the graphs for the first 1000 s in Figure 3b.) 
 
 
Addition of ssA’ to Au-D-S-ssA, at a salt concentration of 100 mM, 
resulted in an increase in size of approximately 4 nm (Figure 1d). This is a 
result of the binding of the biotinhexaethylene glycol-oligonucleotide, ssA’, 
to the DNA immobilized on the gold nanocrystals, ssA. The increase in size 
by 4 nm can be attributed to the biotin-hexaethylene glycol moiety of the 
ssA’. Further addition of Au-D-S-ssA’ had no significant effect on the size. 
This implies that the immobilized ssA has already formed duplexes with the 
ssA’, hence Au-DS- ssA’ is unable to bind to Au-D-S-ssA and form 
duplexes (NOTE: This experiment is graphically illustrated in Supporting 
Information). A similar experiment, whereby Au-D-S-ssA was also added 
after 3000 s to a solution of Au-D-S-ssA’ and ssA, at a salt concentration 
of 100 mM, yielded similar results. 
Several nonspecific interactions involving streptavidin could lead to 
an increase in the observed size due to the “sticky” nature of the protein.41 
To account for this possibility, an equimolar concentration of Au-D-S-ssA 
was added to a dispersion of streptavidin-coated gold, Au-D-S, at 100 mM 
salt concentration. The size increased from 28 to 36 nm (Figure 1d) and 
remained constant over time. This value is an average of the average 
hydrodynamic diameter for both Au-D-S-ssA (42 nm) and Au- D-S (28 
nm). Thus, no significant increase in size is observed as a result of the 
addition of DNA-modified gold to the “sticky” streptavidin-coated gold.  
Similar results were obtained for the addition of Au-D-S-ssA’ to Au-D-S 
under similar conditions.  
Hence, it can be concluded that any streptavidin unbound by ssDNA 
oligomers will not affect the aggregation process. 
 
Controlling the Extent of Nanocrystal Aggregation. Having 
established that duplex formation is driving the aggregation process, it was 
expected that the aggregation of a dispersion of Au-D-S-ssA and Au-D-S-
ssA’, at a salt concentration of 100 mM, would be rapidly inhibited by the 
addition of an excess of either ssA or ssA’ (Figure 2a). This is a 
consequence of the ssDNA oligomers possessing higher diffusion coefficients 
and diffusing at a faster rate to the DNA immobilized on the gold 
nanocrystals compared to the DNA-modified nanocrystals, which possess 
lower diffusion coefficients. 
It is also clear that the average aggregate size depends on the time 
elapsed between the initiation of aggregation and the time that a monolayer 
equivalent of ssDNA oligomers is added to the aggregating colloid. Hence, it 
should be possible to determine the average aggregate size, depending on 
the time of addition of ssDNA. 
Shown in Figure 2a is the addition of ssA oligomers to an aggregating 
colloid of Au-D-S-ssA and Au-D-S-ssA’. It is found that nanocrystal 
aggregation can be inhibited almost immediately at any stage of the 
aggregation process. Representative TEM images (Figures 2b-I, 2b-II, 2b-
III) show that correspondingly narrower particle size distributions are also 
obtained, depending on the time of addition of the ssA oligomers. The size 
distributions become narrower due to the smaller aggregates present in the 
aggregating dispersion diffusing together to form larger aggregates, thereby 
narrowing the size distribution of the aggregates. A similar effect is also 
observed for the addition of ssA’ oligomers to an aggregating dispersion of 
Au-D-S-ssA and Au-D-S-ssA’. 
However, it must be emphasized that as a result of the subjective 
nature of TEM, plus effects such as the evaporation rate of the solvent and 
interactions between nanoparticles and the substrate, measurement of the 
exact sizes of the aggregates may prove unreliable by TEM. Hence, the 
images shown are only representative and the principle insight gained from 
this TEM study is that relatively narrower size distributions are obtained as 
aggregation is terminated at later stages of growth. The TEM images, 
therefore, substantiate and provide qualitative information about the 
quantitative results obtained from DLS. 
 
Controlling the Rate of Nanocrystal Aggregation. As can be seen 
in Figures 3a and 3b, the rate of aggregation of Au- D-S-ssA and Au-D-S-
ssA’, can be controlled by varying either the nanocrystal or the salt 
concentration independently of one another.  
 
Since the rate of DNA duplex formation is dependent on several 
variables, it would be expected that controlling one or more of these 
parameters would provide a means of controlling the kinetics of assembly. 
 
Figure 3a simply shows that the rate of aggregation, at a constant 
salt concentration of 100 mM, increases as the particle concentration is 
increased. A power-law dependence of the aggregate size on time was 
observed for the three different concentrations. 
 
Figure 3b corresponds to samples, at a constant particle 
concentration, aggregated at varying salt concentrations. The slopes of the 
graphs of these individual aggregation processes, which correspond to the 
rates of aggregation, were also plotted against the salt concentration for the 
first 1000 s of aggregation in a log-log plot (Figure 3c). Data obtained at 
later stages in the aggregation process were not taken into account as a 
result of inaccuracies in the calculation of the average hydrodynamic 
diameter for increasing aggregate sizes (42). The resulting plot reveals a 
linear increase in the rate of growth as the salt concentration is increased. 
The rate of aggregation, however, remained constant beyond a salt 
concentration of 100 mM. Hence, it can be seen that up to 100 mM salt 
concentration, the rate of growth, which we can assume to be proportional 
to the rate of duplex formation between the DNA-modified nanocrystals, is 
dependent on the salt concentration. Above this particular concentration 
(i.e., at higher salt concentrations) the rate of growth remains constant. 
Therefore, the aggregation process is dependent on the salt concentration 
to a significantly lesser extent. Consequently, we can also assume that 
under these conditions the rate is much less dependent on the rate of 
duplex formation. These findings would suggest that two distinct kinetic 
regimes for growth exist. 
 
Reaction versus Diffusion-Limited Aggregation Kinetics. 
Previous studies on colloidal aggregation have revealed a transition from 
Reaction Limited-Aggregation (RLA) to Diffusion- Limited Aggregation (DLA) 
for the irreversible growth of colloids (42). In such studies, the stability of 
charge-stabilized colloids is affected by the addition of salt, which reduces 
the extent of interparticle screening. The amount of salt added determines 
the kinetics of the subsequent aggregation process. At low salt 
concentration the aggregation is limited by the sticking probability upon 
approach of two nanocrystals and is slow, i.e., Reaction-Limited Aggregation 
(RLA). At high salt concentration, aggregation is limited solely by the Stokes 
diffusion of the aggregates and is fast, i.e., Diffusion-Limited Aggregation 
(DLA). 
A crossover from RLA kinetics to DLA kinetics can be observed for 
DNA-mediated nanocrystal assembly as presented here. It can be seen in 
Figure 3b that salt concentrations up to 100 mM increase the rate of growth 
of nanocrystals. Hence, it is assumed that the rate of growth of DNA-
modified nanocrystals, which is directly proportional to the rate of duplex 
formation, increases as the salt concentration increases, i.e., RLA kinetics. 
However, at salt concentrations greater than 100 mM, the rate of growth 
remains constant. Hence, it is assumed that the rate of duplex formation is 
no longer the limiting factor governing the kinetics of aggregation. In this 
regime, DLA kinetics are observed as it is assumed that the rate of 
aggregation is now dependent on the diffusion of DNA-modified 
nanocrystals. 
This crossover from RLA kinetics to DLA kinetics, depending on the 
salt concentration, could potentially impact upon the ordering of aggregates 
formed. For aggregates formed under RLA conditions, the collision time 
between particles is longer than for particles aggregated under DLA 
conditions. As a result, this may allow a degree of restructuring among the 
aggregating particles, which would result in a more ordered structure. 
Likewise, particles aggregated under DLA conditions would be expected to 
give rise to a less ordered structure because relatively short collision times 
would diminish the opportunities for the aggregates to restructure. Studies 
to examine the relationship between the salt concentration and the 
resultant ordering of such assemblies using more conclusive techniques to 
probe the aggregate ordering are presently ongoing. 
 
Conclusions 
 
The preparation of biotinylated gold nanocrystals subsequently 
modified by the addition of streptavidin-DNA conjugates has been 
described.  
It has been shown that the modified nanocrystals can be directly 
programmed to recognize one another and assemble in solution by 
combining separate sets of nanocrystals with complementary strands of 
DNA.  
The extent of aggregation can be controlled by the addition of ssDNA 
oligomers to an aggregating colloid of the gold nanocrystals modified with 
complementary strands of DNA. The ssDNA oligomers rapidly form duplexes 
with the immobilized DNA and the aggregation process can be instantly 
terminated. Depending on the time of addition of the ssDNA oligomers, this 
enables one to limit the size of the aggregates formed.  
The rate of formation of the resulting aggregates can be controlled by 
varying the salt and modified nanocrystal concentrations. Two distinct 
regimes of kinetic aggregation, Reaction- Limited Aggregation (RLA) and 
Diffusion-Limited Aggregation (DLA), are observed depending on the salt 
concentration.  
Moreover, the approach adopted is modular, requiring only the 
relevant biotin linker chemistry to be developed for a given nanoparticle, 
and precludes unfavorable interactions between the DNA and the 
streptavidin-coated nanoparticle. 
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